Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
about
AID and APOBECs span the gap between innate and adaptive immunityHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsPrototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3GComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsTime-Resolved Imaging of Single HIV-1 Uncoating In Vitro and in Living CellsLabeling of multiple HIV-1 proteins with the biarsenical-tetracysteine systemProbing the structural states of human immunodeficiency virus type 1 pr55gag by using monoclonal antibodies.HIV-1 uncoating is facilitated by dynein and kinesin 1The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells.Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage responseThe antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes.Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexinHuman immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.APOBEC4 Enhances the Replication of HIV-1.Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon.Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexesvif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.Role of Vif in human immunodeficiency virus type 1 reverse transcriptionHIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blastsHIV taken by STORM: super-resolution fluorescence microscopy of a viral infectionHuman immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif.Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay.Induction of HIV-1 latency and reactivation in primary memory CD4+ T cellsDeterminants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet
P2860
Q21131084-73F31789-03DE-43EE-9053-E7A3CD682644Q24619114-60A11701-0A42-46EF-B6CC-52CDB7175964Q24629953-0E3C17F1-E263-431C-B55D-1C79EA210BA7Q24678970-11E68A96-E838-49C6-824A-9013B2A49004Q27313409-B8F3D831-DDB1-4A1D-A5C8-B84306C54FC3Q28742843-2FC21FC8-52C3-4DDD-B2C6-08865891600CQ30481367-878FC5A7-3A19-47F6-8CF6-D84B5C3F0B40Q30603540-2725379D-AC7A-4906-B884-C960A4770F5BQ31011512-70292CB9-0306-41E3-AF9C-D2814A313BD1Q31036545-037CEE6B-5242-43AC-BD44-A2BBF098B163Q33262244-F6CB70D0-A1EE-463F-AF84-39919FEAA450Q33508241-CE3F7C20-1790-4CE1-BFCA-C56F0132F6E2Q33615181-4399455E-1965-4FBD-B53D-C52B223D0D9EQ33662120-CE2BFED2-8300-441E-BCF9-63BC46F715D2Q33782866-4F26AF72-087A-45FE-B5F0-4CA3E44B69CCQ33802684-EF7D228F-C565-44C2-AEF6-7CA539182931Q33806688-3FA68EA8-2B48-4825-BEFB-BDFCB03EB027Q33841920-2CD405A3-3B2A-404B-86B2-E640C48D08A9Q33852465-616B6DCB-B9E1-43F9-A43D-6C75DBB6404DQ33853536-84D0167F-96C3-413B-95C1-C117ABADC870Q34312616-AAB5A3EA-D201-4600-A4C4-4F7A539E486BQ34345408-44E7D159-AF48-4632-A958-8381F14B1286Q34355599-99453A43-7BE9-44F6-ABBC-71CBE70C7B66Q34465108-049D751B-3084-4092-8E69-CBCAE71C1B41Q34529142-7F24F15C-F06E-46A2-80A2-4FD39CB0264AQ34539110-982C4836-B7F7-4CAE-9213-EABE673F4C04Q35089155-9393D97E-285A-4B4E-B37F-96DBC9E75E21Q35750430-8C4F695A-5FFC-480C-B11A-666FE4086279Q35866134-819BC9FB-A0D8-4F62-8D44-EC503334A3FCQ35866177-FD4C2728-5619-47EA-911E-7F72D0294AF2Q35873067-4FA42CB9-5476-4921-A111-0DFB3874E664Q35873743-D696570A-7FF4-4682-AEF3-9432B4C15643Q35925041-D4590DE8-A5CF-4CD9-B801-43E243D46B52Q36130228-F3184EA4-5212-4472-823E-CDB816126B7DQ36548864-E7053094-924F-4D71-B922-DA482B33E2EBQ36805150-9524F632-7560-463A-8C29-5C7A598A4315Q37028427-77E21477-617E-4D81-9937-57FAA8A6D7C9Q37039142-4FC3C43B-5C1D-4722-8A04-4175428D22F6Q37059673-2CCB70C5-D13B-4898-9C9B-2D6A413C019DQ37104705-B152C944-B4CC-4335-A90C-5E717DBA225E
P2860
Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@ast
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@en
type
label
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@ast
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@en
prefLabel
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@ast
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@en
P2093
P2860
P1433
P1476
Aberrant Gag protein compositi ...... roduced in primary lymphocytes
@en
P2093
P2860
P304
P407
P577
1995-07-01T00:00:00Z